By furthering our investment in women’s cancer datasets, COTA is eager to collaborate with industry partners on accelerating research into these conditions with the goal of improving experiences and outcomes for the hundreds of thousands of women affected by cancer every year.| COTA Healthcare
We’re setting our sights on solid tumors to bring even more clarity and understanding to the cancer community. Our datasets now include longitudinal treatment and outcomes data for a broad array of solid tumors.| COTA Healthcare
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]| COTA Healthcare
CAILIN addresses these questions through training on COTA's proprietary datasets while guided by in-house oncology expertise. CAILIN expedites access to data and oncology-specific insights across the pharmaceutical R&D life cycle and, in the near future, will provide additional ways to develop hypotheses and generate evidence.| COTA Healthcare